Kinnate Biopharma Inc. Research and Development Expenses 2021-2023 | KNTE
Kinnate Biopharma Inc. research and development expenses from 2021 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Kinnate Biopharma Inc. Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $91 |
| 2022 | $88 |
| 2021 | $67 |
| 2020 | $29 |
| 2019 | $9 |
| 2018 | $6 |
| Kinnate Biopharma Inc. Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $13 |
| 2023-09-30 | $25 |
| 2023-06-30 | $26 |
| 2023-03-31 | $27 |
| 2022-12-31 | $25 |
| 2022-09-30 | $24 |
| 2022-06-30 | $20 |
| 2022-03-31 | $20 |
| 2021-12-31 | $20 |
| 2021-09-30 | $19 |
| 2021-06-30 | $16 |
| 2021-03-31 | $13 |
| 2020-12-31 | $12 |
| 2020-09-30 | $8 |
| 2020-06-30 | $6 |
| 2020-03-31 | $3 |
